Loading...
15 Genetic Disorder Drugs Reports
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Abbvie, Gilead Sciences, Mylan, Alaxia, Vertex Pharmaceuticals
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Amicus Therapeutics, EpiVax, Sanofi, Avrobio, Astellas Pharma
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Bayer, Pfizer, Takeda Pharmaceuticals, Sanofi, Novo Nordisk
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Pfizer, Bayer, Novo Nordisk, CSL Limited (CSL Behring), BioMarin
Study Period: 2020 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Bayer, Novartis, Pfizer, Sanofi, Bluebird Bio
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Bluebird Bio, Novartis, ApoPharma, Bellicum Pharmaceuticals, Pfizer
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: CSL Behring, Grifols, Takeda Pharmaceuticals, Octapharma, Bio Products Laboratory
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: CSL Behring, Takeda Pharmaceuticals, Pharming Healthcare, Sanofi, BioCryst Pharmaceuticals
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia Pacific
Major Players: NIPPON SHINYAKU CO., LTD. (NS Pharma Inc.), ITALFARMACO S.p.A., PTC Therapeutics, Santhera Pharmaceuticals, Sarepta Therapeutics
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Novartis, Emmaus Medical, Sanofi, Bluebird bio, Inc., Pfizer
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific
Major Players: AstraZeneca, Clovis Oncology, Pfizer, Onxeo, GlaxoSmithKline
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Pfizer, Alnylam Pharmaceuticals, Teva Pharmaceutical Industries, Neurocrine Biosciences, Ionis Pharmaceuticals
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia-Pacific
Major Players: REGENXBIO, Clinigen Group, JCR Pharmaceuticals, ArmaGen, Takeda Pharmaceuticals
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific
Major Players: Sanofi, Takeda Pharmaceuticals, Amicus Therapeutics, ISU ABXIS, JCR Pharmaceuticals
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Sanofi, Global Blood Therapeutics, Bluebird Bio, EMI Holding, Celgene
Filter Reports
By Region
By Countries
